Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leta Ko"'
Autor:
Francesco Simeone, Moayed Ibrahim, Priya Pal, Charles C. Smith, James E. Robinson, Bo Ning, Joshua L. Denson, Tim Peterson, David M. Mushatt, Leta Ko, Gaynelle Davis, Nakhle S. Saba, Aniko S. Vigh, Ishwarya Satyavarapu, Adeem Nachabe, Karin Halvorson, Tony Y. Hu, April McDougal, Alfred Luk, Alex Niu, William R. Robinson, Wallace Jones, Francisco Socola, Hana Safah, Sukhmani Gill, Elise Tatje, Kevin J. Zwezdaryk
Publikováno v:
Transfusion Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7863eb670493f5eced69167d084fce08
Autor:
Brian E. Lewis, Neeraj Agarwal, Andrew W. Hahn, Leta Ko, Patrick Cotogno, Roberto Nussenzveig, Marcus Marie Moses, Elisa Ledet, Charlotte Manogue, Jodi Lyn Layton, Michael B. Lilly, Pedro C. Barata, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 37:320-320
320 Background: Approximately 20-30% of men with metastatic castration-resistant prostate cancer (mCRPC) seem to respond to enzalutamide (ENZA) after prior exposure to abiraterone acetate and steroids (AA). The impact of genomic changes in androgen r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6402ca67eddac08336d98da2c3bc2467
https://doi.org/10.1200/jco.2019.37.7_suppl.320
https://doi.org/10.1200/jco.2019.37.7_suppl.320
Autor:
Patrick Cotogno, Elisa Ledet, Charlotte Manogue, Jodi Lyn Layton, A. Oliver Sartor, Brian E. Lewis, Lahiru Ranasinghe, Lynne Chapman, Bryce Raymon Christensen, Leta Ko, Marcus Marie Moses, Peter Steinwald, Joshua Schiff, James Vu
Publikováno v:
Journal of Clinical Oncology. 37:254-254
254 Background: Circulating tumor-derived DNA (ctDNA) is an accessible method for characterizing tumoral alterations. We report ctDNA screenings of mCRPC patients (pts) who have had germline testing. Methods: Guardant360 (Guardant Health, Inc.) asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee84efa10a4d44a7b7e440ff09a97275
https://doi.org/10.1200/jco.2019.37.7_suppl.254
https://doi.org/10.1200/jco.2019.37.7_suppl.254
Autor:
Elisa Ledet, Charlotte Manogue, A. Oliver Sartor, Brian E. Lewis, Lynne Chapman, Lahiru Ranasinghe, Patrick Cotogno, Joshua Schiff, Bryce Raymon Christensen, Peter Steinwald, Jodi Lyn Layton, Marcus Marie Moses, Leta Ko, James Vu
Publikováno v:
Journal of Clinical Oncology. 37:247-247
247 Background: Characterization of circulating free DNA (ctDNA) may aid understanding of the pathophysiology of metastatic castrate resistant prostate cancer (mCRPC). The goal of this study was to evaluate and compare somatic alterations in ctDNA be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ab2f17665e54e1a76aa1c90045499d8
https://doi.org/10.1200/jco.2019.37.7_suppl.247
https://doi.org/10.1200/jco.2019.37.7_suppl.247